pharma news today glp-1 GLP-1s and the Unintended Consequences of the $100 Billion Market GLP-1 Agonists Weight Loss Drugs

The research article noted the following findings: 44% lower all-cause mortality 31% lower risk of pulmonary embolism 17% lower risk of venous thromboembolism 21% lower emergency department visits Earlier studies have shown similar results in people with diabetes and chronic kidney disease (CKD)

However, TAD2 shows only a mild preference for an -helical conformation, which appears to be slightly stabilized in presence of FOXO4 FH (Supplementary Fig

Kennedy BP, Bottiglieri T, Arning E, Ziegler MG, Hansen LA, Masliah E (2004) Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function

Tomer Y (2014) Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics